News | September 27, 2024
Alkem denies claims of Pan-D, Clavam 625 batches being substandard quality
The samples of both products mentioned in the CDSCO list are spurious and not manufactured by Alkem
The samples of both products mentioned in the CDSCO list are spurious and not manufactured by Alkem
Krsnaa Diagnostics receives LoI from RINPAS for radiology services
Quinidine Sulphate helps manage rare irregular heartbeat conditions
These clinical studies support the interchangeability of adalimumab-fkjp at low-concentration with high-concentration adalimumab and ustekinumab biosimilarity
NMC to continue its efforts to improve and enhance the quality of medical education in the country
Focus on consolidation could help them strengthen their position in the competitive pharmaceutical industry, potentially driving expansion and improving efficiencies
This office will be the central hub for all operations related to companies ethical pharmaceutical business
Tremelimumab (Imjudo) in combination with Durvalumab (Imfinzi) is indicated for the treatment of patients with unresectable hepatocellular carcinoma
This approval reflects company’s unwavering commitment that the quality assurance
New indication supported by the MANDARA trial which showed nearly 60% of patients achieved remission and 41% of patients fully stopped taking oral corticosteroids
Subscribe To Our Newsletter & Stay Updated
